Nestlé reports three-month sales for 2022

In This Article:

Nestlé S.A.
Nestlé S.A.

[Ad hoc announcement pursuant to art. 53 SIX Listing Rules]

This press release is also available in Français (pdf) and Deutsch (pdf)

Follow today's event live
14:00 CEST Investor call audio webcast
Full details on our website

.............


Vevey, April 21, 2022

Nestlé reports three-month sales for 2022




  • Organic growth reached 7.6%, with real internal growth (RIG) of 2.4% and pricing of 5.2%. Growth was broad-based across most geographies and categories, with increased pricing, continued momentum in retail sales and a further recovery in out-of-home channels.

  • Total reported sales increased by 5.4% to CHF 22.2 billion (3M-2021: CHF 21.1 billion). Foreign exchange decreased sales by 0.8%. Net divestitures had a negative impact of 1.3%.

  • Portfolio management on track. In April, Nestlé Health Science completed the acquisition of a majority stake in Orgain, a leader in plant-based nutrition.

  • Full-year 2022 outlook confirmed: we expect organic sales growth around 5% and underlying trading operating profit margin between 17.0% and 17.5%. Underlying earnings per share in constant currency and capital efficiency are expected to increase.

Mark Schneider, Nestlé CEO, commented:"In these first months of the year, the war in Ukraine has caused unspeakable human suffering. We remain focused on supporting our colleagues there and providing humanitarian relief, while standing with the international community in the call for peace.

Amid this challenging environment, we delivered strong organic sales growth with resilient RIG. We stepped up pricing in a responsible manner and saw sustained consumer demand. Cost inflation continues to increase sharply, which will require further pricing and mitigating actions over the course of the year. The Nestlé team addressed these headwinds and advanced our long-term strategy and sustainability objectives with agility and determination. We confirm our guidance for the year."

Total Group

Zone North America

Zone Europe

Zone AOA

Zone Latin America

Zone Greater China

Nespresso

Nestlé Health Science

Other Businesses

Sales 3M-2022 (CHF m)

22 238

5 800

4 633

4 633

2 697

1 361

1 602

1 449

63

Sales 3M-2021 (CHF m)*

21 089

5 887

4 535

4 497

2 357

1 265

1 571

930

47

Real internal growth (RIG)**

2.4%

1.4%

2.8%

1.7%

4.7%

3.8%

0.2%

4.3%

30.7%

Pricing**

5.2%

8.5%

4.1%

4.3%

7.7%

- 0.5%

3.1%

1.3%

3.6%

Organic growth**

7.6%

9.9%

6.9%

6.0%

12.5%

3.4%

3.3%

5.6%

34.3%

Net M&A**

- 1.3%

- 13.6%

0.6%

- 0.1%

0.1%

0.0%

0.6%

50.1%

0.0%

Foreign exchange**

- 0.8%

2.2%

- 5.4%

- 2.8%

1.8%

4.2%

- 2.0%

0.2%

- 0.6%

Reported sales growth

5.4%

- 1.5%

2.2%

3.0%

14.4%

7.6%

2.0%

55.8%

33.6%


* 2021 figures restated following the creation of Zone North America (NA) and Zone Greater China (GC) as of January 1, 2022. Zone AOA includes Middle East and North Africa (MENA) previously included in Zone EMENA.
** RIG, pricing and organic growth figures exclude the Russia region, with a corresponding impact on the M&A and foreign exchange lines. Organic growth would have been higher including the Russia region.